Ezapro, a recombinant human type II tumor necrosis factor receptor antibody fusion protein, is clinically useful in the treatment of rheumatoid arthritis. This kind of drug can be used for rheumatoid arthritis and ankylosing spondylitis in clinic, and can also be used for moderate to severe plaque psoriasis in adults. Recombinant human type II tumor necrosis factor receptor antibody fusion protein has more adverse reactions, which may lead to redness, swelling, itching, pain and other symptoms at the site of inoculation, and patients may also experience dizziness, rash, insomnia, cough and other adverse reactions. Note that patients with sepsis and active tuberculosis who are allergic to the product are prohibited from using such drugs. It should also be noted that the use of this product should be suspended in patients with recurrent upper respiratory tract infections and serious infections such as secondary infections in diabetes. Recombinant human type II tumor necrosis factor receptor antibody fusion protein belongs to the prescription drugs, need to use the drug under the guidance of a specialist, do not self-medication.